XML 38 R27.htm IDEA: XBRL DOCUMENT v3.26.1
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of fair value of financial liabilities
         
Description  Level  January 31, 2026  April 30, 2025
Liabilities:               
Warrant liabilities   3   $13,657,000   $338,000 
Derivative liabilities   3   $1,136,000   $ 
Schedule of change in the fair value warrant liability
   
   Three Months Ended January 31, 2026
Balance on October 31, 2025  $16,152,000 
Issuance of warrants    
Warrant exercises   (599,135)
Change in fair value of warrant liability   (1,895,865)
Balance on January 31, 2026  $13,657,000 

 

    Nine Months Ended January 31, 2026 
Balance on April 30, 2025  $338,000 
Issuance of warrants   5,583,000 
Warrant exercises   (599,135)
Change in fair value of warrant liability   8,335,135 
Balance on January 31, 2026  $13,657,000 
Schedule of change in the fair value derivative liability
     
    Three Months Ended January 31, 2026  
Balance on October 31, 2025   $ 1,693,000  
Issuance of Series C convertible preferred stock      
Change in fair value of derivative liability     (557,000 )
Balance on January 31, 2026   $ 1,136,000  

 

    Nine Months Ended January 31, 2026  
Balance on April 30, 2025   $  
Issuance of Series C convertible preferred stock     1,995,000  
Change in fair value of derivative liability     (859,000 )
Balance on January 31, 2026   $ 1,136,000  
Schedule of fair values of financial instruments by class
         
          
   Level  January 31, 2026  April 30, 2025
Financial Assets               
Marketable equity securities   1   $372,251   $366,316 
Money market account   1   $2,081,636   $76,287 
Convertible note receivable – investment in debt security - Femasys   3   $   $3,696,000 
Warrant asset - Femasys   3   $906,000   $3,061,000 
Investment in preferred stock - QCLS   3   $22,472,000   $22,474,000 
Warrant assets - QCLS   3   $10,242,000   $8,618,000